US2008182896A1PendingUtilityA1

Use of metal chelates in human or animal feeding

Assignee: AGRISTUDIO SRLPriority: Sep 6, 2002Filed: Feb 14, 2008Published: Jul 31, 2008
Est. expirySep 6, 2022(expired)· nominal 20-yr term from priority
A23L 33/165A23K 20/30A23L 33/175A23K 20/142A61P 3/00
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the use in human and animal nutrition (monogastric and polygastric animals) of known chelates of bivalent metal Mg, Ca, Mn, Co, Cu, Zn and Fe with methionine hydroxy analogue. The present invention further relates to a method for preparing new chelates with methionine hydroxy analogue, both in solid form with iron (II), vanadium (iV) and (V) and molybdenum (V) and (VI), and in liquid form in aqueous solution with iron (II) and (III) and chrome (III). Eventually, the present invention relates to the use of said new chelates, both in solid form with iron (II), vanadium (IV) and (V) and molybdenum (V) and (VI), and in liquid form in aqueous solution with iron (II) and (III) and chrome (III), in human and animal nutrition.

Claims

exact text as granted — not AI-modified
1 - 25 . (canceled) 
     
     
         26 . A stable aqueous solution comprising iron (III) and/or chrome (III) complexed with MHA in which the molar ratio MHA/M(III) is ≧2. 
     
     
         27 . A method for preparing an integrator, comprising a step in which MHA is reacted with an aqueous solution of a soluble iron (III) or chrome (III) salt. 
     
     
         28 . The stable aqueous solution according to  claim 26 , wherein the composition further comprises iron(II) complexed with MHA. 
     
     
         29 . The method according to  claim 27 , wherein at least a metal chelate selected from the group consisting of:
   (CH 3 SCH 2 CH 2 CH(OH)COO) 2 M. n H 2 O  (I)   in which: M is a bivalent metal cation chosen from the group comprising: Mg, Ca, Mn, Co, Cu, Zn and Fe, and n is between 0 and 6;   Vanadium oxide and MHA present in a molar ratio (Vanadium/MHA) of 1:2 to 1:8;   Molybdenum oxide or salt complexed with MHA is further added to the integrator.   
     
     
         30 . A method of treating a human being or an animal suffering from a deficiency of metal oligoelements comprising iron and/or chrome, said method comprising the step of treating said human being or animal with an integrator according to  claim 27 . 
     
     
         31 . The method according to  claim 30 , wherein the deficiency of metal oligoelements comprising iron and/or chrome is of iron (III) and/or chrome (III).

Join the waitlist — get patent alerts

Track US2008182896A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.